Next Article in Journal
A Sterol from Soft Coral Induces Apoptosis and Autophagy in MCF-7 Breast Cancer Cells
Next Article in Special Issue
Phycochemical Constituents and Biological Activities of Fucus spp.
Previous Article in Journal
Computational Methodologies in the Exploration of Marine Natural Product Leads
Open AccessReview

Overview on the Antihypertensive and Anti-Obesity Effects of Secondary Metabolites from Seaweeds

cE3c—Centre for Ecology, Evolution and Environmental Changes/Azorean Biodiversity Group & Faculty of Sciences and Technology, University of Azores, Rua Mãe de Deus, 9501-321 Ponta Delgada, Portugal
Department of Chemistry & QOPNA-Organic Chemistry, Natural Products and Food Stuffs, University of Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal
Author to whom correspondence should be addressed.
Mar. Drugs 2018, 16(7), 237;
Received: 11 June 2018 / Revised: 20 June 2018 / Accepted: 12 July 2018 / Published: 14 July 2018
(This article belongs to the Special Issue Discovery and Application of Macroalgae-Derived Natural Products)
Hypertension and obesity are two significant factors that contribute to the onset and exacerbation of a cascade of mechanisms including activation of the sympathetic and renin-angiotensin systems, oxidative stress, release of inflammatory mediators, increase of adipogenesis and thus promotion of systemic dysfunction that leads to clinical manifestations of cardiovascular diseases. Seaweeds, in addition to their use as food, are now unanimously acknowledged as an invaluable source of new natural products that may hold noteworthy leads for future drug discovery and development, including in the prevention and/or treatment of the cardiovascular risk factors. Several compounds including peptides, phlorotannins, polysaccharides, carotenoids, and sterols, isolated from brown, red and green macroalgae exhibit significant anti-hypertensive and anti-obesity properties. This review will provide a comprehensive overview of the recent advances on bioactive pure compounds isolated from different seaweed sources focusing on their potential use as drugs to treat or prevent hypertension and obesity. On the other hand, although it is obvious that macroalgae represent promising sources of antihypertensive and anti-obesity compounds, it is also clear that further efforts are required to fully understand their cellular mechanisms of action, to establish structure-inhibition relationships and mainly to evaluate them in pre-clinical and clinical trials. View Full-Text
Keywords: seaweeds; anti-hypertension; anti-obesity; peptides; phlorotannins; fucoxanthin seaweeds; anti-hypertension; anti-obesity; peptides; phlorotannins; fucoxanthin
Show Figures

Graphical abstract

MDPI and ACS Style

Seca, A.M.L.; Pinto, D.C.G.A. Overview on the Antihypertensive and Anti-Obesity Effects of Secondary Metabolites from Seaweeds. Mar. Drugs 2018, 16, 237.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop